EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Diffusion of new technology for the treatment of renovascular hypertension in the United States: surgical revascularization versus catheter-based therapy, 1988-2001



Diffusion of new technology for the treatment of renovascular hypertension in the United States: surgical revascularization versus catheter-based therapy, 1988-2001



Journal of Vascular Surgery 40(4): 717-723



Background: Trends in the management of renovascular hypertension were evaluated by using a representative national database to determine whether a shift in treatment technology and outcomes has occurred. Methods: Clinical information regarding the treatment of renovascular hypertension in 5433 patients from 1988 to 2001 was derived from the Nationwide Inpatient Sample (NIS) database. Patients were classified into 3 groups: combined aortic and renal revascularization, isolated renal revascularization, and catheter-based procedures (angioplasty with or without stenting). Population-based trends were determined by using sampling weights for each year to estimate the total number of each intervention in the United States. Outcomes were compared using multivariate logistic regression analysis for risk-adjustment. Results: A 73% decrease in combined aortic and renal revascularizations (P =.033) and a 56% decrease in isolated renal revascularizations (P <.001) occurred during the study period. Catheter-based procedures have increased 173% from 0.4 to 1.1 procedures per 100,000 adults during this same time period (P <.001). Predictors favoring catheter-based treatment were admission acuity, increasing age, nonwhite race, and high socioeconomic status. Predictors of mortality for all 3 treatment groups included increasing age, emergent admission, and nonwhite race. Conclusions: A significant change in the management of patients with renovascular hypertension has occurred, with a shift towards less invasive catheter-based interventions. A better understanding of the diffusion of this technology in the treatment of individuals with renovascular hypertension will influence the training and distribution of future vascular specialists responsible for these patients.

(PDF emailed within 0-6 h: $19.90)

Accession: 011960648

Download citation: RISBibTeXText

PMID: 15472600

DOI: 10.1016/j.jvs.2004.07.029



Related references

Therapy of renovascular hypertension in neurofibromatosis: surgical revascularization versus percutaneous transluminal angioplasty. Vasa. Zeitschrift für Gefasskrankheiten 25(4): 368-372, 1996

Subclavian and Innominate Revascularization: Surgical Therapy Versus Catheter-Based Intervention. Current Interventional Cardiology Reports 2(2): 101-110, 2000

Renovascular hypertension. Surgical treatment of renal revascularization. Prensa Medica Argentina 56(37): 1754-1755, 1969

Therapy of renovascular hypertension in neurofibromatosis: Operative revascularization versus percutaneous transluminal angioplasty. Vasa 25(4): 368-372, 1996

Repeat revascularization versus nephrectomy in the treatment of recurrent renovascular hypertension. Surgery, Gynecology & Obstetrics 162(1): 37-42, 1986

Catheter intervention and surgical treatment of renovascular hypertension due to Kawasaki disease. Kato, H International Congress Series; Kawasaki disease 544-548, 1995

Percutaneous angioplasty and surgical revascularization in renovascular hypertension: experience in treatment and long-term follow up in 124 patients. Arquivos Brasileiros de Cardiologia 62(6): 417-423, 1994

Results of medical versus surgical treatment of renovascular hypertension. Clinical Science and Molecular Medicine. Supplement 45 Suppl 1: 89s-893, 1973

Survival of dialysis patients in the United States after percutaneous versus surgical coronary revascularization Is there a clear choice?. Circulation. 106(19 Supplement): Ii-492, Ember 5, 2002

Surgical revascularization in children with renovascular hypertension. Urologia Internationalis 57(2): 110-114, 1996

Surgical versus medical treatment in renovascular hypertension. Retrospective study of 166 cases. Nephron 44 Suppl 1: 105-108, 1986

Surgical revascularization for renovascular hypertension and preservation of renal function. Laragh, J H, Brenner, B M Hypertension: Pathophysiology, diagnosis, and management, Second edition, Vols 1 and 2 2055-2068, 1995

Enalapril versus triple-drug therapy in the treatment of renovascular hypertension. Drugs 30 Suppl 1: 59-69, 1985

Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation 124(9): 1046-1058, 2011